Cargando…

Blood-based Markers in the Prognostic Prediction of Esophagogastric Junction Cancer

Esophagogastric junction cancer poses a great threat to human beings both in western countries and East Asia, especially in China and Japan, and its incidence has increased during recent decades. The 5-year survival rate of esophagogastric junction cancer is quite poor compared with that of other ga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Can-Tong, Hong, Chao-Qun, Huang, Xu-Chun, Li, En-Min, Xu, Yi-Wei, Peng, Yu-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255356/ https://www.ncbi.nlm.nih.gov/pubmed/32489452 http://dx.doi.org/10.7150/jca.44545

Ejemplares similares

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

A novel nomogram based on clinical blood indicators for prognosis prediction in curatively resected esophagogastric junction adenocarcinoma patients
por: Liu, Can-Tong, et al.
Publicado: (2023)

Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma
por: Liu, Can-Tong, et al.
Publicado: (2020)

Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma
por: Ding, Tian-Yan, et al.
Publicado: (2022)

Circulating Levels of L1-cell Adhesion Molecule as a Serum Biomarker for Early Detection of Gastric Cancer and Esophagogastric Junction Adenocarcinoma
por: Chu, Ling-Yu, et al.
Publicado: (2020)

Prognostic Value of Intraoperative Blood Transfusion in Patients with Adenocarcinoma of the Esophagogastric Junction
por: Nakajima, Kei, et al.
Publicado: (2022)

Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2019)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
por: Li, Shengli, et al.
Publicado: (2023)

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
por: Zhou, Zhangjian, et al.
Publicado: (2015)

Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2015)

Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction
por: Zheng, Yi-Han, et al.
Publicado: (2022)

Short‐term postoperative complications and prognostic factors in patients with adenocarcinoma of the esophagogastric junction
por: Zhang, Hui, et al.
Publicado: (2018)

Current treatments and outlook in adenocarcinoma of the esophagogastric junction: a narrative review
por: Cao, Fei, et al.
Publicado: (2022)

Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction
por: Xiong, Jianping, et al.
Publicado: (2020)

Prognostic value of stem cell markers in esophageal and esophagogastric junction cancer: a meta-analysis
por: Trevellin, Elisabetta, et al.
Publicado: (2020)

Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia
por: Oh, Sung Eun, et al.
Publicado: (2023)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
por: Sun, Lidan, et al.
Publicado: (2014)

Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction
por: Wei, Zhi-Jian, et al.
Publicado: (2022)

Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021)

The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma
por: Li, Zheng, et al.
Publicado: (2021)

Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction
por: Han, Wen-xiu, et al.
Publicado: (2016)

Surgical options for submucosal tumors near the esophagogastric junction: does size or location matter?
por: Huang, Yi-Chun, et al.
Publicado: (2020)

Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy
por: Ming, Jiao, et al.
Publicado: (2023)

Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis
por: Li, Yanhong, et al.
Publicado: (2019)

Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option
por: Hu, Can, et al.
Publicado: (2018)

Esophageal Stent for Cervical Esophagus and Esophagogastric Junction
por: Shim, Chan Sup
Publicado: (2012)

Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019)

Esophagogastric Junction Outflow Obstruction Caused by Gabapentin
por: Barret, Maximilien, et al.
Publicado: (2019)

Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
por: Xu, Haitao, et al.
Publicado: (2020)

Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma
por: Tang, Weifeng, et al.
Publicado: (2019)

Screening and clinical significance of lymph node metastasis‐related genes within esophagogastric junction adenocarcinoma
por: Han, Rui, et al.
Publicado: (2021)

Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery
por: Zheng, Chengbin, et al.
Publicado: (2020)

Prognostic Value of Perineural Invasion in Esophageal and Esophagogastric Junction Carcinoma: A Meta-Analysis
por: Gao, Aiqin, et al.
Publicado: (2016)

Esophagogastric Junction Outflow Obstruction Transformed to Type II Achalasia
por: Shin, In Seub, et al.
Publicado: (2016)

Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction
por: Xu, Jinming, et al.
Publicado: (2017)

Primary malignant melanoma of the esophagogastric junction: A case report
por: Chu, Yu-Ming, et al.
Publicado: (2021)

Utilizing Intrabolus Pressure and Esophagogastric Junction Pressure to Predict Transit in Patients With Dysphagia
por: Jeong, Su Hyeon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9hekbk2sfs55m1evemkbihn9dn